1-4 of 4
plexiform neurofibroma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mast cells and the neurofibroma microenvironment

Karl Staser, Feng-Chun Yang, D. Wade Clapp
Journal: Blood
Blood (2010) 116 (2): 157–164.
https://doi.org/10.1182/blood-2009-09-242875
Published: 2010
Journal Articles

Mast Cells and Tumor Progression.

D. Wade Clapp, MD, Fengchun Yang, MD, PhD, David A. Ingram, Jr., MD, Kent A. Robertson, MD, PhD, Gary D. Hutchins, PhD, Luis F. Parada, PhD
Journal: Blood
Blood (2009) 114 (22): SCI-33.
https://doi.org/10.1182/blood.V114.22.SCI-33.SCI-33
Published: 2009
Journal Articles

Imatinib Mesylate Reduces Plexiform Neurofibromas by Targeting the Hematopoietic Microenvironment.

Feng-Chun Yang, MD, PhD, David Ingram, M.D., Shi Chen, M.D., Ph.D., Kent Robertson, M.D., Ph.D., Xiohong Li, Jin Yuan, Scott Knoll, Whitney Horn, Gary Hutchins, M.D., Ph.D., L. Parada, Ph.D., David Wade Clapp, M.D.
Journal: Blood
Blood (2007) 110 (11): 1915.
https://doi.org/10.1182/blood.V110.11.1915.1915
Published: 2007
Journal Articles

Mast Cells Are Integral Components of the Tumor Microenvironment That Are Required for Plexiform Neurofibroma Progression.

Fengchun Yang, MD, PhD, David A. Ingram, MD, Shi Chen, MD, Jin Yuan, Xiaohong Li, Whitney Horn, Luis Parada, PhD, D. Wade Clapp, MD
Journal: Blood
Blood (2006) 108 (11): 677.
https://doi.org/10.1182/blood.V108.11.677.677
Published: 2006